Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT E MCCLURE

Allopathic & Osteopathic Physicians Family Medicine

NPI
1447253786
CMS profile
337774
Location
CANEYVILLE, KY

General Payments · PY2018–2024

$3,515.75

  • Reported across 242 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$285.40

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $285.40 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $833.70 65
PY2019 $589.45 44
PY2020 $677.00 45
PY2021 $444.26 30
PY2022 $227.34 16
PY2023 $458.60 26
PY2024 $285.40 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $20.66 06/12/2024 Food and Beverage Undisputed 01/23/2026 1117624232 CMS
AstraZeneca Pharmaceuticals LP $14.86 12/09/2024 Food and Beverage Undisputed 01/23/2026 1105696254 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.01 04/30/2024 Food and Beverage Undisputed 01/23/2026 1118011845 CMS
Corcept Therapeutics $19.01 03/27/2024 Food and Beverage Undisputed 01/23/2026 1117793076 CMS
Gilead Sciences, Inc. $24.34 05/14/2024 Food and Beverage Undisputed 01/23/2026 1133742703 CMS
GlaxoSmithKline, LLC. $13.66 05/14/2024 Food and Beverage Undisputed 01/23/2026 1116335849 CMS
GlaxoSmithKline, LLC. $13.55 07/24/2024 Food and Beverage Undisputed 01/23/2026 1116594434 CMS
Lilly USA, LLC $13.25 02/05/2024 Food and Beverage Undisputed 01/23/2026 1135336373 CMS
Lilly USA, LLC $16.03 03/18/2024 Food and Beverage Undisputed 01/23/2026 1135368442 CMS
Lilly USA, LLC $15.24 10/14/2024 Food and Beverage Undisputed 01/23/2026 1135336377 CMS
Lilly USA, LLC $15.62 11/19/2024 Food and Beverage Undisputed 01/23/2026 1135359472 CMS
Mylan Specialty L.P. $15.98 10/29/2024 Food and Beverage Undisputed 01/23/2026 1147322874 CMS
Novo Nordisk Inc $16.82 10/08/2024 Food and Beverage Undisputed 01/23/2026 1097012663 CMS
Novo Nordisk Inc $21.78 11/20/2024 Food and Beverage Undisputed 01/23/2026 1097584520 CMS
Ultragenyx Pharmaceutical Inc. $20.84 07/15/2024 Food and Beverage Undisputed 01/23/2026 1153283307 CMS
Ultragenyx Pharmaceutical Inc. $24.75 08/19/2024 Food and Beverage Undisputed 01/23/2026 1153282668 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.